Enliven Therapeutics Inc. (ELVN)
ELVN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$39.49
-3.31% on the day
Market cap
$2.9B
Mid cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ELVN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001672619 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-12 |
| Latest annual report | 10-K | 2026-03-03 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEFA14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 789 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.5% |
| 1 month | -26.7% |
| 3 months | -23.1% |
| Year to date | +153.9% |
| 1 year | +89.0% |
| From 52-week high | -36.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RCUS | Arcus Biosciences Inc. | $22.51 | -7.52% | $2.9B |
| DYN | Dyne Therapeutics Inc. | $15.30 | -4.13% | $2.9B |
| PGEN | Precigen Inc. | $7.48 | -2.35% | $2.7B |
| ACAD | ACADIA Pharmaceuticals Inc. | $18.62 | -4.07% | $3.2B |
| ZLAB | Zai Lab Limited | $23.10 | -6.06% | $2.6B |
| PBLS | Parabilis Medicines Inc. | $26.85 | -7.25% | $3.3B |
| ARQT | Arcutis Biotherapeutics Inc. | $26.09 | -0.50% | $3.3B |
| IDYA | IDEAYA Biosciences Inc. | $34.26 | -4.99% | $3.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier